COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Other: Placebo
Drug: Dutasteride

First Posted Date: 2009-09-28

Last Posted Date: 2016-05-17

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 16

Registration Number: NCT00985738

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes

Phase 4

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Sugar Pill
Drug: Sitagliptin

First Posted Date: 2009-09-17

Last Posted Date: 2010-03-30

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 20

Registration Number: NCT00978796

Locations: 🇺🇸
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States

The Effect of Protandim on Non-alcoholic Steatohepatitis

Not Applicable

Completed

Conditions: Non-Alcoholic Steatohepatitis

Interventions: Dietary Supplement: Protandim
Dietary Supplement: Placebo

First Posted Date: 2009-09-16

Last Posted Date: 2013-02-05

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 70

Registration Number: NCT00977730

Locations: 🇺🇸
University of Colorado at Denver and Health Sciences Center, Denver, Colorado, United States

Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Other: Control
Other: 20% basal insulin reduction
Drug: Terbutaline

First Posted Date: 2009-09-10

Last Posted Date: 2013-10-11

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 16

Registration Number: NCT00974051

Locations: 🇺🇸
Barbara Davis Center, Aurora, Colorado, United States

Analysis of Calcium Balance in Chronic Kidney Disease

Not Applicable

Completed

Conditions: Chronic Kidney Disease

Interventions: Dietary Supplement: High calcium diet 2000 mg/day
Dietary Supplement: Low calcium diet, 800 mg/day

First Posted Date: 2009-09-10

Last Posted Date: 2012-12-05

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 16

Registration Number: NCT00974532

Locations: 🇺🇸
University of Colorado Denver Health Sciences Center, Denver, Colorado, United States

Autoimmune Thyroid Disease Genetic Study

Completed

Conditions: Hashimoto's Disease
Graves' Disease

First Posted Date: 2009-08-13

Last Posted Date: 2015-05-28

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 199

Registration Number: NCT00958113

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Martial Arts as Early Intervention for Teen Drug Abuse

Not Applicable

Completed

Conditions: Adolescent
Substance Use

Interventions: Behavioral: Modified traditional martial arts training

First Posted Date: 2009-08-11

Last Posted Date: 2013-06-20

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 31

Registration Number: NCT00956527

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns

Phase 2

Completed

Conditions: Bronchopulmonary Dysplasia

Interventions: Drug: Inhaled Nitric Oxide (iNO)
Drug: Nitrogen (placebo)

First Posted Date: 2009-08-10

Last Posted Date: 2017-06-15

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 124

Registration Number: NCT00955487

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Children's Hospital and University Colorado Hospital, Aurora, Colorado, United States
🇺🇸
Anne and Robert H. Lurie Children's Hospital of Chicago and Northwestern Memorial Hospital, Chicago, Illinois, United States

and more 3 locations

Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation

Not Applicable

Terminated

Conditions: Liver Transplantation
Ischemia/Reperfusion Injury
Oxidative Injury

Interventions: Drug: Nitric Oxide

First Posted Date: 2009-07-29

Last Posted Date: 2021-05-28

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 13

Registration Number: NCT00948194

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Effect of Antacids on the Pharmacokinetics of Raltegravir

Phase 1

Completed

Conditions: HIV Infections

Interventions: Drug: raltegravir
Drug: antacid

First Posted Date: 2009-07-23

Last Posted Date: 2017-06-28

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 17

Registration Number: NCT00944307

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy